Idexx Laboratories (IDXX) Common Equity (2009 - 2026)
Idexx Laboratories' Common Equity came in at $1.61 billion for Q2 2026, up 10.5% from $1.46 billion a year earlier and up 3.6% from the prior quarter.
Powered by 
Analysis
Idexx Laboratories (IDXX) Common Equity (2009 - 2026) Analysis & Trends
Going back to Q4 2009, Idexx Laboratories' Common Equity data covers 66 quarters.
- Common Equity has increased in each of the last three years, with a five-year compound annual growth rate of 20.5% (FY2020 to FY2025).
- Going back by year, Common Equity was $1.6 billion in FY2024 (+7.5%), $1.48 billion in FY2023 (+143.9%), $608.74 million in FY2022 (-11.8%) and $689.99 million in FY2021 (+9.0%).
- The Q2 2026 figure represents the highest quarterly Common Equity since Q3 2024.
- Year-over-year, Common Equity has increased for three consecutive quarters, with growth averaging 4.0% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q3 2023 (growth of 172.6%), and the weakest in Q2 2022 (a decline of 38.9%).
- Business Quant data shows IDXX's Common Equity at $1.56 billion (Q1 2026), $1.61 billion (Q4 2025) and $1.56 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Idexx Laboratories | 40.86 Bn | 40.07 Bn | 779.09 Mn | 1.61 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.61 Bn |
| Mar 31, 2026 | 1.56 Bn |
| Dec 31, 2025 | 1.61 Bn |
| Sep 30, 2025 | 1.56 Bn |
| Jun 30, 2025 | 1.46 Bn |
| Mar 31, 2025 | 1.45 Bn |
| Dec 31, 2024 | 1.60 Bn |
| Sep 30, 2024 | 1.62 Bn |
| Jun 30, 2024 | 1.58 Bn |
| Mar 31, 2024 | 1.57 Bn |
| Dec 31, 2023 | 1.48 Bn |
| Sep 30, 2023 | 1.30 Bn |
| Jun 30, 2023 | 1.09 Bn |
| Mar 31, 2023 | 841.10 Mn |
| Dec 31, 2022 | 608.74 Mn |
| Sep 30, 2022 | 476.00 Mn |
| Jun 30, 2022 | 457.01 Mn |
| Mar 31, 2022 | 639.80 Mn |
| Dec 31, 2021 | 689.99 Mn |
| Sep 30, 2021 | 755.46 Mn |
API Access
Idexx Laboratories Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IDXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IDXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IDXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();